Cargando…

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer

PURPOSE: Immunotherapy has become widely applied in non-small cell lung cancer (NSCLC) patients. However, the relatively low response rate of immunotherapy monotherapy restricts its application. Combination therapy improves the response rate and prolongs patient survival; however, adverse events (AE...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yahan, Wang, Jiao, Hu, Yanting, Cao, Pikun, Wang, Gang, Cai, Hongchao, Wang, Meixiang, Yang, Xia, Wei, Zhigang, Ye, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459232/
https://www.ncbi.nlm.nih.gov/pubmed/36091128
http://dx.doi.org/10.3389/fonc.2022.938827